KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

about

Cancer treatment and the KIR-HLA system: an overview.

P2860

Q39131056-DC13D54C-B704-4671-AFCF-BFBCFFB6DD0B

P2860

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

Item

http://www.wikidata.org/entity/Q46105174

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

@en

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

@nl

type

Item

label

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

@en

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

@nl

prefLabel

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

@en

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

@nl

P1476

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

@en

P2093

A John Barrett

http://www.w3.org/2001/XMLSchema#string

Catherine Sobieski

http://www.w3.org/2001/XMLSchema#string

Christopher Allen

http://www.w3.org/2001/XMLSchema#string

David Linch

http://www.w3.org/2001/XMLSchema#string

David Marin

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Hila Shaim

http://www.w3.org/2001/XMLSchema#string

Jerome G Saltarrelli

http://www.w3.org/2001/XMLSchema#string

Kai Cao

http://www.w3.org/2001/XMLSchema#string

Katayoun Rezvani

http://www.w3.org/2001/XMLSchema#string

P2860

Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Up on the tightrope: natural killer cell activation and inhibition

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL.

Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family.

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.

Human natural killer cells.

MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.

P304

2819-2823

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2016-05-713099

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Hagop Kantarjian

Guillermo Garcia-Manero

P577

2016-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27760759

http://www.w3.org/2001/XMLSchema#string

P932

5159704

http://www.w3.org/2001/XMLSchema#string

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

about

P2860

P2860

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932